Listed in Alphabetical Order

Dr Denis Bauer

Senior Research Scientist, Research Team Leader, Bioinformatics, The Australian E-Health Research Centre, CSIRO

Dr Denis Bauer is CSIRO’s Principal Research Scientist in transformational bioinformatics and an internationally recognised expert in machine learning and cloud-based genomics, having presented at AWS Summit, Mumbai and Canberra, (2019,18) and Alibaba Infinity, Singapore 2018. Her achievements include developing open-source machine-learning cloud services that accelerate disease research and being used by 10,000 researchers annually.

Cloud-native Machine Learning Necessary to Meet the Health Analytics Challenges of the Future: Thursday 19th September, 3:05pm-3:30pm

Dr Julian Brown

Clinical Lead & Director, Prescribing Services

Dr. Julian Brown is a General Practitioner in West Norfolk and founder of Eclipse Solutions. His web-based systems are now protecting more than 10 million patients.

He has been a GP for 23 years and has had a special interest in diabetes since 2006. He was the GP Prescribing Lead for Norfolk from 2008-2013 and the Long Term Conditions Lead for West Norfolk CCG from 2013-2015. He is considered one of the leading experts on admission avoidance systems and is researching the improvement of outcomes through automated patient feedback, best practice identification and patient self-manangement plans.

He is passionate about optimising health economics through IT and the utilisation of population health management.

Delivering Precision Based Patient Care for the NHS: Thursday 19th September, 10:00am-10:35am

Associate Professor Luke Burchill

Associate Professor of Medicine (Cardiology), Royal Melbourne Hospital Adult Congenital Heart Disease Program

University of Melbourne Department of Medicine

Associate Professor Burchill’s research focuses on cardiovascular health in the indigenous setting. His MRFF-funded project is a collaboration between indigenous health researchers and clinicians with data scientists, biostatisticians and health economists which aims to investigate several factors and observed trends in CV disease in the indigenous Australian cohort. The project aims to explore several distinct themes and areas in CV disease and care in the cohort, including CV disease risk, differences in CV disease and care between indigenous and non-indigenous Australians and the impact of evidence-based CV care on health outcomes and economic savings. The research findings will be translated through collaboration with public health and primary care groups to devise strategies for improved implementation of evidence-based CV care for indigenous Australians, with potential for application on a federal scale as a national indigenous CV implementation science initiative.

Closing the Gap: Indigenous Health and Data Sovereignty: Thursday 19th September, 1:10pm-1:25pm

Professor Enrico Coiera

Professor of Medical Informatics and Director, Centre for Health Informatics at Macquarie University

Trained in medicine with a computer science PhD in Artificial Intelligence (AI), Professor Coiera is Foundation Professor in Medical Informatics at Macquarie University and Director of the Centre for Health Informatics, a group he co-founded in 2000. With a research background in industry and academia, he has a strong international research reputation for his work on decision support and communication processes in biomedicine.

He spent 10 years at the prestigious Hewlett-Packard Research Laboratories in Bristol UK where he led numerous health technology projects. He has overseen the development and trial of multiple e-Health interventions, including the Healthy.me consumer system and clinical decision support systems.

Artificial Intelligence Today: Thursday 19th September, 2:15pm-2:40pm

Professor Gemma Figtree

Professor, Medicine, Northern Clinical School, Kolling Institute of Medical Research, Member of the Charles Perkins Centre

Gemma Figtree is a Professor in Medicine at the University of Sydney. She co-leads the Cardiovascular Theme for Sydney Health Partners, a NHMRC Advanced Health Research and Translation Centre and is the Chair of the University of Sydney’s multi-disciplinary Cardiovascular Initiative. Gemma completed her DPhil at Oxford University in 2002 supported by a Rhodes Scholarship making fundamental discoveries regarding estrogen’s actions and factors regulating NO/redox balance in the cardiovascular system. She is committed to improving the care for heart attack patients- using her knowledge of molecular and cellular biology to develop methods of identifying those at highest risk of adverse outcome, and discovering novel therapies to prevent and treat events, inspired by her clinical work as an interventional cardiologist. She has dedicated herself throughout her career to unravelling key mechanisms underlying susceptibility and response to heart attack, with studies extending from the bench to large cohort studies and clinical trials. Discoveries in her Laboratory have been published in leading journals Circulation, JACC and European Heart Journal, with > 140 publications. GF is a principal investigator on grants >$8 mill. Having recently completed a co-funded NHMRC CDF and Heart Foundation Future Leader Fellowship, she was awarded a National Health and Medical Research Council (NHMRC) Excellence Award for Top Ranked Practitioner Fellow (Australia), commencing in 2018. In 2019 she received the prestigious NSW Ministerial Award for Cardiovascular Research Excellence. She is committed to the advancement of her field and serves as a member of the Editorial Board of leading international cardiovascular journals Circulation and Cardiovascular Research, as well as being a founding editorial board member for Redox Biology, and an Associate Editor for Heart, Lung and Circulation. Her research and clinical perspective and leadership are recognised by her membership of the Scientific Board of Cardiac Society of Australia and New Zealand (responsible for International Relations), and her appointment to the Expert Advisory Panel for NHMRC Structural Review of Grants Program (2016-17), and as well as the Clinical Committee of the Heart Foundation. She is committed to the promotion and advocacy of cardiovascular research, working as President of the Australian Cardiovascular Alliance with a national team to secure $220 Million Federal funding for the Mission for Cardiovascular Health, as well as a member of the NSW CVD Advisory Committee.

Optimising Detection of Heart Disease at its Early Stages: Friday 20th September, 10:00am-10:25am

Professor Ian Frazer

Professor, Faculty of Medicine, Affiliate Professor, the University of Queensland Diamantina Institute

Affil Professorial Research Fellow, Institute for Molecular Bioscience, University of Queensland

Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers.  He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council. Most recently appointed chair of the federal governments Medical Research Future Fund.

HPV Vaccine: From Inception to a World First Impact: Friday 20th September, 10:55am-11:30am

Sara Gloede

Cancer Screening Quality Improvement Officer, Cancer Institute NSW

Sara is an public health professional with experience and interest in a range of areas including cancer screening, primary care quality improvement, social marketing and non-communicable disease prevention and control in the Pacific.

Over the past decade Sara has supported the design and implementation of national social marketing campaigns targeting women’s physical activity in the Pacific, non-communicable disease policy and programs in the Kingdom of Tonga, the ‘Women’s Cancer Screening Collaborative’ for North Coast Primary Health Network and the development of Cancer Institute NSW’s ‘Cancer screening and primary care: a quality improvement toolkit’.

Sara holds a Bachelor of Business (Marketing), a Masters of Applied Anthropology and Community Development and a Masters of Public Health (Social Marketing).

Cancer Screening and Primary Care: a Quality Improvement Toolkit: Friday 20th September, 12:00pm-12:25pm

Professor Kim Greaves

Director of Cardiac Research and Senior Staff Specialist, Sunshine Coast Hospital and Health Services

Professor, Faculty of Science, Health, Education and Engineering, University of Sunshine Coast

I was appointed as Director of Cardiac Research and Senior Staff Specialist at the Sunshine Coast Hospital and Health Services, and Professor at the Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, in July 2013. Prior to this I was Professor of Cardiology at Bournemouth University, UK, and Director of Cardiology in Poole Hospital NHS Foundation Trust, Dorset. In 2013 I moved to Australia with my family with two main career goals: (1) to establish the cardiology department and SCHHS as a centre of research excellence in Australia (2) to improve the overall health of the community. I am supervisor to several PhD students and have projects underway looking at the effects of insulin on the skeletal and cardiac blood flow, cardiovascular screening, work place health and integration of primary care data with secondary care. 

Cardiovascular Disease Risk Assessment – All You Need to Know: Friday 20th September, 9:25am-9:00am

Scientia Professor Mark Harris

Scientia Professor and Exec Director of Centre for Primary Health Care and Equity, UNSW

Scientia Professor and Exec Director of Centre for Primary Health Care and Equity, UNSW. Research is mainly in chronic disease prevention and management, integrated care and health equity. Clinical work is with refugees denied access to health care by the Australian government.

Professor Harris is internationally acclaimed for his public health and primary care research. He became a Fellow of the Australian Academy of Health and Medical Science in 2015, was appointed Scientia Professor at UNSW from 2013-2018, was an NHMRC Senior Professorial Research Fellow from 2011-2015 and became an Honorary Life Fellow of the RACGP in 2009. He was won numerous awards for his work, including the 2013 Muru Marri Indigenous Health Impact Prize, the 2013 Peter Baume Public Health Impact Award, a 2010 Humanitarian Award (Health category) and the 2010 Charles Bridges-Webb Medal from the Australian Association for Academic Primary Care.

Precision Education and Quality Improvement in General Practice: Friday 20th September, 1:10pm-1:40pm

Dr Sam Heard

CEO, Medical Director at the Central Australian Aboriginal Congress, Associate Professor at Flinders University 

Dr Sam Heard is a is a practicing clinician with a diverse range of international experience, including roles in inner London (UK) and the Northern Territory (Australia), where he assisted with the standardisation of health information to empower clinicians and their patients – and improve health care and outcomes. During his career, Sam has held senior positions in London and Australian Universities, as well as Australian Professional Colleges. He ran the GP training program for the Northern Territory for many years and was also chairperson of the National Education Committee of the Royal Australian College of General Practitioners for three years. As an active GP obstetrician, Sam continues to practice medicine when at home in Darwin (Australia) – sharing his skills where there is a major shortage of clinicians. Sam developed clinical software for general practice in London in 1985, was a leader of the Good European Health Record (GEHR) project, and has been active in heath informatics ever since. He has published widely on both clinical and e-health subjects and has presented at numerous conferences around the world.

Sam has been an Australian representative to international standards meetings and was a foundation co-Chair of the HL7 Electronic Health Record Technical Committee (EHR TC). To add to his wealth of experience, Sam was an invited observer and contributor to the CEN EN 13606 standards meetings, and is a key contributor to Standards Australia. Sam was also a member of the IHTSDO Implementation and Innovation committee of (2009-10). In 1997, Sam was responsible for the development of some of the key concepts of knowledge-based e-health including archetypes, with Thomas Beale. Sam developed the original product concepts for the Archetype Editor, Ocean Terminology Service and subset builder, and the Clinical Knowledge Manager (CKM). 

Precision Based Health Care in Indigenous Communities: Friday 20th September, 12:30pm-12:50pm

Dr Stephen Hollings

CEO, the Heart Research Institute

Dr Stephen Hollings is CEO of the Heart Research Institute.

He is a senior executive and non-executive director with extensive experience in highly competitive, customer-driven industries. He has successfully led businesses through periods of growth and development as well as through times of unprecedented change created by economic turbulence, industry restructuring and disruptive technology.

In his various Chair, CEO and senior executive roles he has become known for providing a strong focus on and a personal commitment to the development of emerging leaders, providing organisations with a robust talent pipeline. He has played a key role as an executive coach and mentor for over 20 years.

He has consulted to companies on strategy, digital opportunities as well as challenges, and marketing, with a portfolio skewed to the health sector.

Dr Hollings sits on the Board of the Heart Research Institute (UK), Relationships Australia (NSW) and is Chair of RASE Pty Limited. Currently he is also deputy Chair of the Global Access Partners’ National Standing Committee on Energy and the Environment.

Cardiovascular Research: On the Trail to Save Lives and Limbs: Thursday 19th September, 12:15pm-12:45pm

Emma Hossack

CEO, Medical Software Industry Association (MSIA)

Emma Hossack is the CEO of the Medical Software Industry Association (MSIA). MSIA represents over 90% of the providers of all the providers of health software in Australia. Over 91% of all MBS/PBS transactions involve MSIA member software.

Prior to this appointment in December 2018, Emma was the CEO of Extensia, a leading Australian supplier of software solutions and technologies for the health care sector. Additionally, Emma was the CEO of Binder, an information logistics platform used across all industry sectors. Before acquiring Extensia, Emma practiced as a commercial lawyer as a Senior Associate with a National Law Firm based in Melbourne and in 2007 she completed a Master of Laws at Queensland University of Technology, majoring in consent models and privacy compliant sharing of health information. Now based in Brisbane, Emma’s other interests and positions include membership of the Health Informatics Society Australia, Past President and current member of iappANZ (Australian and New Zealand International Association of Privacy Professionals) and representative on many jurisdictional and Commonwealth Government reference groups and boards. 

Transparency: How Software Enhances Privacy and Health: Thursday 19th September, 4:40pm-5:00pm

Dr Mary Kavurma

Group Leader of the Vascular Complications Group and Associate Director of Research and Education, the Heart Research Institute

Dr. Mary Kavurma is Group Leader of the Vascular Complications Group and Associate Director of Research and Education at the Heart Research Institute. She has a conjoint Senior Lecturer appointment at the University of Sydney and is Secretary of the Australian Atherosclerosis Society. Mary received her PhD in 2003 from the Centre for Vascular Research, and in 2004 moved to the UK, Cambridge University an NHMRC CJ Martin Fellow, returning back in 2007. During her time back in Sydney, she established her independent research, joining the Heart Research Institute as Head of the Vascular Complications Group in 2013. Mary’s research interests are focused on understanding fundamental mechanisms in molecular and cellular biology leading to intimal thickening, atherosclerosis and its complications. She has held numerous Fellowships (NHMRC, HF and UNSW) and Project grants (NHMRC, HF). Mary has an active interest in promoting medical research to the lay community. Her achievements in scientific research, communication and community engagement were acknowledged with a Young Tall Poppy Science Award. 

Cardiovascular Research: On the Trail to Save Lives and Limbs: Thursday 19th September, 12:15pm-12:45pm

Associate Professor Sarah Kummerfeld

Head of Science of the Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research

Associate Professor Sarah Kummerfeld had an interest in genetics from a young age. After hearing a talk on the emerging field of bioinformatics by Dr Karl, she decided to study the unique combination of genetics and computer science for her undergraduate degree at the University of Sydney.

It was during her PhD in computational biology at the University of Cambridge that Dr Kummerfeld became interested in genomics. The human genome project was nearing completion, and its findings were opening up a whole new field of research. With access to the full repertoire of human genes, Dr Kummerfeld developed algorithms to predict the structure and function of proteins encoded by the genome.

Now, Dr Kummerfeld joins KCCG as its scientific head while also leading its translational genome informatics team. In the future, Dr Kummerfeld plans to use her role as head of KCCG’s translational genome informatics team to study complex conditions like osteoporosis and chronic pain.

Genomic Technologies for Whole of Life Healthcare: Thursday 19th September, 2:40pm-3:05pm

Professor Glen Maberly

Senior Staff Specialist Endocrinology, Blacktown and Mt Druitt Hospitals

Director, Western Sydney Diabetes Integrated and Community Health, Western Sydney Local Health District

Prof Glen Maberly is a Senior Staff Specialist Endocrinologist at Blacktown and Mt Druitt Hospitals, and the Director Western Sydney Diabetes at Western Sydney Local Health District.

Currently Glen is the driving force behind the Western Sydney Diabetes (WSD), which was set up to address the epidemic of diabetes in greater western Sydney, where it is estimated that more than 50 per cent of its residents are overweight or obese, and at high risk of diabetes. 

Throughout his career, Prof Maberly has focused on fostering public-private-civic partnerships and bring public health evidence based research findings to large scale implementation.

Patients and Clinicians Beating Diabetes Together: Friday 20th September, 1:40pm-2:05pm

Dr Vladislav Matic

Chairman, Northern Queensland PHN

Dr Vladislav Matic MBBS (Syd) M. Bus (Mgmt) FACRRM FRACGP FAICD has had extensive experience in the provision of primary and secondary health care. Until recently Dr Matic was the Director of Medical Services at Wuchopperen Health Service, a position he took up in early 2011. Prior to working in Cairns, Dr Matic was a rural Procedural GP (Anaesthetics) and Visiting Medical Officer serving remote communities for more than 18 years. Dr Matic currently works as a Medical Management Consultant providing advice on Clinical and Corporate Governance, Financial Performance, Data Governance, CQI, Accreditation and Compliance to ACCHOs and corporate health providers.

Dr Matic has served on numerous health boards at the local, state, and national level for more than 20 years. Previous experience includes roles as Vice-Chair Australian Divisions of General Practice, Chair of the Alliance of NSW Divisions and Chair of Outback Division of General Practice. Dr Matic is currently a Board Member of the Remote Vocational Training Scheme, and Chair of the RVTS AMS Reference Group. In addition to governance roles, Dr Matic has also been appointed to several national advisory boards and committees, including Practice Incentive Program Advisory Group, Practice Incentive Program Technical Working Group and the Pharmacy Trials Advisory Group.

Dr Matic has a strong interest in improving the health outcomes of Aboriginal and Torres Strait Islander people and is the Australian College of Rural and Remote Medicine’s nominee to the NQPHN Board. When not working Dr Matic enjoys cycling, reading and travelling.

Three Strategies to Improve Indigenous Health and Welfare: Friday 20th September, 2:05pm-2:30pm

Matthias Merzenich

Quality Assurance and Training Manager, Pen CS

Matthias has a degree in Nutrition and a post-graduate diploma in Information Technology. He has worked in public health, health information and IT systems training since 1997. Initially working in the public sector in the NT and Far North QLD, he has been providing training for PenCS software users across Australia since 2005. He has worked on consultancy jobs in the Pacific on a number of public health/health information related jobs and has a keen interest in data and public health.

PIP QI Panel Q&A: Thursday 19th September, 11:50am-12:00pm

Dr Michael Moore

CEO, Central and Eastern Sydney PHN

Michael Moore trained as a GP, doing his internship at Hornsby Hospital, gained his FRACGP, and after some years in hospital administration took up the role of CEO at Hornsby Ku-ring-gai Division of General Practice in 1992.  

Michael oversaw Hornsby’s merger with Ryde Division of General Practice, and moved across to Central Sydney in 2002. He then managed Central Sydney Division’s amalgamation with Canterbury, and in 2012 organised the transition of the amalgamated organisation across to Inner West Sydney Medicare Local, becoming the Medicare Local’s new CEO. 

In June 2015 he was successful in his application to become CEO of Central and Eastern Sydney PHN, which covers the regions previously covered by Eastern, South Eastern, and Inner West Sydney Medicare Locals.

Michael is a passionate about optimising the contribution of primary and community based care to the health of our wider community, and has maintained an active interest in general practice throughout this time, hence his great sympathy for busy clinicians everywhere.

PHN General Practice Expectations: Thursday 19th September, 11:25am-11:50am

Samantha Moubarak

Senior Manager, Systems Integration Monitoring & Evaluation (SIME), System Information & Analytics (SIA) Branch, NSW Ministry of Health

Samantha is a Senior Manager in the System Information and Analytics Branch at the NSW Ministry of Health. She has over seven years’ experience in data analysis, risk assessment, and large scale project management and delivery in the health sector.

Samantha completed her studies in Actuarial Studies and Finance at the University of NSW and started her career at EY. After discovering her passion for health, and the power of data to drive evidence based decision making and system reform, Samantha transitioned to the Ministry managing the data strategy for Australia’s first health focused Social Impact Investments.
Samantha is now leading the state-wide implementation of Lumos; a pioneering initiative that links data across primary, ambulatory and acute care enhancing our understanding of the patient journey across the NSW health system. Lumos will provide a platform that can deliver the much-needed insights for health care system reform and improved patient outcomes.

Data Linkage Methods for PHNs: Thursday 19th September, 5:00pm-5:20pm

Dr Harry Nespolon

RACGP President, General Practitioner

Dr Harry  Nespolon  is  the  President  of  the Royal  Australian  College  of  General  Practitioner.  The RACGP  represents  over 41,000  general  practitioners  and  those  doctors  training  to  become  general practitioners.

Both  as  President  and  prior  to  being  elected  to  this  position  he  has  been  regularly  called  upon  to provide  advice  on  clinical and  health  policy  issues by  government,  private  and  public  organisations.

He  has  been  Chair  of  GP  Synergy  leading  it  to  become  the largest  general  practice  training  and  is currently  a  board  member  of Sydney  North  Local Health  District,  responsible  for the  tertiary  health provision  for  nearly  one  million  people  living  on  the  north  shore  and  northern  beaches  of  Sydney.

He  is  a Fellow  of the  Australian  Institute  of company  directors.   He  holds  economic  and  law  digress as  well  as  a  Master  of  Business Administration.   He  has  worked  very  briefly  as  a lawyer,  as  a management  consultant  and  a  Canberra based  health  lobbyist.  

Dinner & Table Talk: ‘Community Wellness’ – The New Paradigm for Better Health: Thursday 19th September, 7:00pm

Phil Offer

CEO, George Health Technologies

Phil Offer is CEO of George Health Technologies, a social enterprise owned by the George Institute for Global Health with operations in Australia, China and India. The George Institute’s focus for the last 20 years has been on non-communicable diseases and how to translate the research to improve the health of millions worldwide. The Times Higher Education Supplement rated it as the top independent medical researcher in Australia. Developed over the last 10 years, its SMARThealth software has been tested on over 300,000 patients. Its clinically proven to deliver a step change in the treatment of multiple chronic diseases combining technology with the potential for new care delivery models. Phil leads the scale up with commercial partnerships across Australia, China and India. Phil has worked in the health technology and telco sectors for 22 years. Before joining the George he was CEO of MedicalDirector and held senior roles for 14 years with Optus.

Precision Prevention – Approaches to Combatting Chronic Diseases: Thursday 19th September, 12:45pm-1:10pm

Lucy Patel

Portfolio Manager – General Practice Development, WA Primary Health Alliance

Lucy is a Registered General Nurse with 25 years’ experience in the health sector. With a background in emergency nursing and telephone and online service delivery, Lucy brings that knowledge to her role at the WA Primary Health Alliance

Lucy oversees the teams responsible for the localization and roll out of WA HealthPathways, Practice Assist (helpdesk for general practice), cancer screening and immunisation initiatives and data in general practice.

State-Wide Implementation of PIP QI: Thursday 19th September, 11:00am-11:25am

Lorraine Pyefinch

Co-founder and Director of Best Practice Software

Lorraine began her working life in nursing, moving into medical software in partnership with her husband, Dr Frank Pyefinch when they established the Medical Director business in 1992.  Growing from an ambitious start-up to the dominant market leader, the MD business was acquired in 1999 by HCN.  Lorraine and Frank started the Best Practice business in 2004 and over the past 15 years, have grown the business to its current position as market leader in GP software with growing market share of Specialist doctors and Allied Health practitioners.  While BpHq remains in the regional city of Bundaberg, Best Practice has offices in Brisbane, Sydney and Hamilton NZ, following strategic acquisitions of similar business developing software.  The business now employs in excess of 150 employees.

Lorraine has been a passionate advocate for regional Queensland having been an elected member in Local Government for 14 years, including four years as Mayor of Bundaberg Regional Council.  Lorraine currently holds the position of Director/Secretary of the Medical Software Industry Association.  As well as her qualifications as a Registered Nurse, Lorraine holds a Bachelor of Health Science (Nursing), and a Masters’ of Management. 

What is the Cloud?: Thursday 19th September, 4:15pm-4:40pm

Martin Rocks

Assistant Secretary, Primary Health Network Strategy Branch, Department of Health

Martin joined the Department of Health in 2003.  He is presently Assistant Secretary of the Primary Health Networks Strategy Branch.  The Branch has national oversight of the PHN program, and also responsibility for the Practice Incentives Program Quality Improvement Incentive.

Previous roles included working across policy and programs in Aboriginal and Torres Strait Islander health and wellbeing, public hospitals, rural health and pharmacy programs.

Martin has also served as a ministerial adviser between 2013 and 2016, with a focus on rural health, alcohol, tobacco and illicit drugs, and Aboriginal and Torres Strait Islander health.

He has an Executive Master of Public Administration through the Australian and New Zealand School of Government.

PIP QI Incentive – 7 weeks in: Thursday 19th September, 10:35am-11:00am

Professor George Rubin

Master of Ceremonies and Associate Medical Director, South Eastern Sydney LHD, Professor of Public Health, USYD and UNSW

George is an associate medical director in South Eastern Sydney Health District and a professor of public health at the Universities of Sydney (Adjunct) and NSW (Conjoint).  In the past he was President of the Australasian Faculty of Public Health Medicine; chaired the Australian Technical Advisory Group on Immunization; and, served as director of Epidemiology and then Chief Health Officer for NSW Health.  He has worked as a medical epidemiologist with the US Centres for Disease Control in Atlanta, USA and in Bangladesh.  He has published more than 150 scientific papers and works clinically as an addiction medicine specialist.

Welcome: Thursday 19th September, 10:00am-10:05am

Improved Heart Wellness Lowers Mortality, Morbidity and Costs: Friday 20th September, 9:50am-10:15am

Tess van der Rijt

CEO and Founder, Patient Connector, and CEO, Medinet Australia

Tess van der Rijt is a health system policy and reform specialist. She has worked with the World Health Organisation in Geneva; in public health governance in Singapore and as a management consultant in Sydney, advising government health agencies and health care service providers. Tess is the CEO and Founder of Patient Connector, an online platform that gives patients upfront access to information about specialist doctors, so they can make more informed decisions about their healthcare.

How We Increase Consumers’ Access to Information So They Can Make More Informed Health Care Decisions: Thursday 19th September, 3:45pm-4:15pm

Dr Ross Walker

Consultant Cardiologist, Sydney Heart Health Clinic

Dr. Ross Walker is an eminent practising cardiologist with a passion for people and health with 40 years experience as a clinician. For the past 20 years he has been focusing on preventative cardiology & is one of Australia’s leading preventative health experts.
Considered one of the world’s best keynote speakers and life coaches, he is the author of seven best-selling books & a regular health presenter in the Australian Media. Dr Ross also appears weekly on the national Macquarie Radio network & the Super Radio network.
Dr Walker runs the Sydney Heart Health Clinic in Lindfield on Sydney’s North Shore, a clinic that focuses on all aspects of non-invasive & preventative cardiology.

Heart Wellness Program: Friday 20th September, 9:00am-9:25am

Dr Tom Wenkart

Conference Convenor, Pen CS Director

Since 1970, Dr Wenkart has been actively involved in commercial activities. The dominant sphere of activities has been in the health and medical industries. Initially as a General Practitioner and then as the owner operator of a large integrated medical corporation, Macquarie Health Corporation Limited. This included establishing what became the largest pathology diagnostic practice in New South Wales; a group of Acute Care Private Hospitals (now 12 locations); and multiple Medical Practice Clinics. In addition, his broader Health Sector interests expanded into computerisation and medical device technologies, including Research and Development, plus manufacturing and retailing.

As Director of Pen CS, Pen CS and CAT Plus became part of the Macquarie Health Corporation in 2011. The unique position which CAT has developed with the medical profession is now a major opportunity for the PHN network.

Introduction: Thursday 19th September, 10:05am-10:10am

Edweana Wenkart

Conference Convenor, Pen CS Director, Business Growth and Development

Edweana Wenkart began her career in film production where she worked on films including Matrix, Moulin Rouge and Australia. In 2003, she founded award-winning Marketing and PR Agency Tsuki managing clients including Volvo, University of Western Sydney and Twentieth Century Fox. In 2017 she joined Pen CS, bringing her vibrant perspective and passion to drive positive evolution to the health tech space. As Director of Pen CS she manages delivery of health informatics software, across Australia in 28 (of 31) Primary Health Networks and 5,700 General Practices with 21 million patient records per month.  Board positions include her role as Director of CareMonitor, board member for Ocean Health Systems and Director of Pen CS.  She holds an MBA from AGSM and a BA from the University of Sydney with a double major in Japanese and Psychology. Edweana lives in Sydney with her husband and two children.

Sum Up and Future Direction: Friday 20th September, 2:50pm-3:00pm

Professor John Zalcberg, OAM

Professor & Tony Charlton Chair of Oncology, Cancer Research Monash University

Professor Zalcberg is currently the Head of the Cancer Research Program as well as NHMRC (MRFF) Practitioner Fellow in the School of Public Health and Preventive Medicine at Monash University – currently overseeing the establishment and activities of clinical quality registries across various tumour types. He is also the inaugural Tony Charlton Chair of Oncology at Alfred Health as well. He was previously the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne from 1997 to 2014 as well as their Chief Medical Officer from 2007 to 2013. He is the current Chair of the Australian Clinical Trials Alliance and serves on the Board of the Australian Red Cross Blood Service.  He is immediate past Chair of the Board of AGITG after serving in this role for over 15 years and a past Board Member of Cancer Trials Australia and past Co-Chair of the Cancer Drugs Alliance. Previous positions also include Board Member of the NSW Cancer Institute, President of the Clinical Oncological Society of Australia. He received a Medal of the Order of Australia Award (OAM), the 2011 Cancer Achievement Award from the Medical Oncology Group of Australia and the 2015 Tom Reeve Award for outstanding contribution to cancer care from the Clinical Oncological Society of Australia (COSA).  In 2014 the AGITG announced the annual “John Zalcberg OAM Award for Excellence in Australasian Gastro-Intestinal Trials Group (AGITG) Research” in his honour.  He has over 280 articles published in peer-reviewed journals and has received funding in excess of $54m over the course of his career.

Cancer Screening – Challenges and Opportunities: Friday 20th September, 11:30am-12:00pm